Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Net Sales $ 10,085 $ 26,327
Operating Expenses:        
Research and development 202,054 109,350 437,787 291,190
General and administrative 472,538 1,082,131 5,251,967 3,052,161
Total operating expenses (674,592) (1,191,481) (5,689,754) (3,343,351)
Loss from operations (664,507) (1,191,481) (5,663,427) (3,343,351)
Other income (expense)        
Other Income / (Expense) (12,818) 21,920 (25,197) 21,921
Change in fair value of derivative liability 340,851 (839,872)
Financing costs (171,739)
Interest expense (including $58,916 and $59,434 to related parties for three months and $175,846 and $176,364 to related parties for nine months) (58,916) (205,038) (321,637) (375,862)
Interest expense - amortization of debt discount (81,959) (747,623) (174,981)
Debt extinguishment, net (including $1,074,602 and $172,456 to related parties for three months and $1,074,602 and $689,747 to related parties for nine months) (1,074,602) (424,331) (423,028) (977,201)
Total other expense (805,485) (689,408) (2,529,096) (1,506,123)
Net Loss $ (1,469,992) $ (1,880,889) $ (8,192,523) $ (4,849,474)
Loss per share - basic and diluted $ (0.01) $ (0.02) $ (0.06) $ (0.05)
Weighted average number of common shares outstanding - basic and diluted 153,322,179 108,542,493 146,164,472 102,376,462